ketamine has been researched along with Hearing Loss in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mülazımoğlu, S | 1 |
| Ocak, E | 1 |
| Kaygusuz, G | 1 |
| Gökcan, MK | 1 |
| Iravani, M | 1 |
| Wald, SH | 1 |
2 other studies available for ketamine and Hearing Loss
| Article | Year |
|---|---|
Retroauricular Approach for Targeted Cochlear Therapy Experiments in Wistar Albino Rats.
Topics: Anesthesia; Anesthetics, Dissociative; Animals; Blister; Cochlea; Hearing Loss; Hypnotics and Sedati | 2017 |
Dexmedetomidine and ketamine for fiberoptic intubation in a child with severe mandibular hypoplasia.
Topics: Analgesics; Anesthesia, Inhalation; Child; Dexmedetomidine; Female; Fiber Optic Technology; Hearing | 2008 |